Back to search
Inflamatory Bowel Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Inflamatory Bowel Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Inflamatory Bowel Disease trials you may qualify forThe goal of this observational, multicenter, descriptive, prospective, and longitudinal study is to evaluate the impact of IBD activity on frailty in a prospect…
Patients with refractory inflammatory bowel disease (IBD) show inadequate response to conventional biologics and small molecule drugs, with persistently active…
This is a prospective, single-center, observational study aimed at evaluating the efficacy and safety of guselkumab in patients with moderate to severe Crohn's…
This study is a prospective, case-control study evaluating whether the PET radiotracer 68Ga-FAPI-46 can detect fibrostenosing Crohn's disease in the small bowel…
he goal this clinical trail is to evaluate the safety、Pharmacokinetic and immunogenicity of GR2303 injection。 Subjects will be enrolled in different groups in s…
Inflammatory bowel disease (IBD) is a group of chronic progressive gastrointestinal diseases that can recur throughout life and for which there is no cure. Biol…
In this study the intestinal microbiome and metabolic profiles of patients with inflammatory bowel disease will be determined upon probiotic intervention.
To study the efficacy of different biological treatment on patient with inflammatory bowel disease after one year of treatment in upper egypt